Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 1,293 shares at $14.00 ($18K) on 2023-09-06, disclosed to the SEC on 2023-09-06.
Scheduled sale ($18k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.46 | 401 | $6K | 32.5% |
| 2 | $13.46 | 871 | $12K | 65.8% |
| 3 | $14.00 | 21 | $294 | 1.7% |
| Total | $13.78 avg | 1,293 | $18K | 100% |
| Filing → |
| TRDA | SELL | 2023-03-03 | $17K | — | Filing → |
| TRDA | SELL | 2023-01-03 | $70K | — | Filing → |
| TRDA | SELL | 2022-10-27 | $537K | — | Filing → |